Recent studies have reported the contribution of cav-1 mutations to the onset of pulmonary arterial hypertension (PAH) [55,56,57,58], a rare and progressive degenerative disease that compromises the lungs vasculature. This evidence concerns the gene CAV1 and pulmonary arterial hypertension.